{"id":"W4232127070","doi":"10.1200/jco.2020.38.15_suppl.tps5101","title":"PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kidney Foundation of Canada; Princess Margaret Cancer Centre; University Health Network; University of Calgary; McMaster University; Juravinski Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Nivolumab; Perioperative; Internal medicine; Neoadjuvant therapy; Kidney cancer; Oncology; Surgery; Urology; Immunotherapy; Kidney; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002764777,0.001795575,0.002796091,0.0003648564,0.0004749278,0.001041004,0.001005667,0.001741724,0.009374931],"category_scores_gemma":[0.002734119,0.0006124837,0.003007497,0.000481208,0.0009446713,0.001082597,0.0006681981,0.003063146,0.001280017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001042824,"about_ca_system_score_gemma":0.001856447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00199273,"about_ca_topic_score_gemma":0.00511809,"domain_scores_codex":[0.9989552,0.0006698648,0.00005864114,0.0001535464,0.00006317502,0.00009948707],"domain_scores_gemma":[0.9988933,0.0003071929,0.0003695293,0.0000939532,0.00008283721,0.0002531456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.982844,0.002210885,0.000656334,0.001569833,0.001475848,0.0000186904,0.00002534712,0.0002313032,0.0008015895,0.0001128448,0.001586643,0.008466695],"study_design_scores_gemma":[0.962644,0.03244554,0.002056336,0.0001095942,0.0009035125,0.0000264387,0.00002181046,0.0001793317,0.000173406,0.0002156758,0.001211063,0.00001322558],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9164861,0.02769466,0.002450945,0.002500194,0.002784806,0.02767047,0.01176082,0.0003816995,0.008270264],"genre_scores_gemma":[0.9502726,0.007950587,0.004620822,0.003242093,0.0007933722,0.0212685,0.004437241,0.00006699698,0.007347728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009374931,"threshold_uncertainty_score":0.0313623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1456851587564778,"score_gpt":0.4030842746793476,"score_spread":0.2573991159228698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}